Dow Jones futures rose on hopes of a stimulus package as the jobs report approaches; DocuSign Eyes Point of Purchase

Dow Jones futures rose modestly Friday morning, along with S&P 500 futures and Nasdaq futures, ahead of the November jobs report, focusing on coronavirus vaccine news and stimulus deal talks.




X



The stock market rally turned mixed on Wednesday afternoon in a report detailing the supply chain issues that were spurred Pfizer (PFE) And the Biotechnology (BNTXWeeks ago, to halve the number of coronavirus vaccine doses by the end of the year. Just before the shutdown, investors took the Pfizer’s vaccine production cut as a brand new.

Shares in Pfizer and BioNTech plunged in initial headlines, while rival Covid-19 vaccine maker tumbled modern (MRNA) Went up.

After closing, DocuSign (DOCUTitles of earnings reports after business hours. DocuSign shares rose overnight, but trimmed initial gains indicating a potential breakout. This came on the heels of previously breaking profits on Thursday CrowdStrike (CRWD), Zscaler (ZS) And the Flex (ESTC).

Limited Coronavirus Vaccine Introduced

Pfizer and BioNTech said weeks ago that they would only be able to deliver 50 million doses of corona virus vaccine By the end of the year due to supply chain issues, versus their previous goal of 100 million doses. A report, on Thursday, stated that this was due to poor raw materials for the vaccine. They still expect to ship more than 1 billion doses of the Covid vaccine in 2021.

The UK just approved a Pfizer vaccine this week, and vaccinations are expected to start next week. The FDA will review the Pfizer-BioNTech vaccine on December 10 and the Coronavirus vaccine Moderna a week later.

Pfizer stock fell 1.7% on Thursday, with BioNTech down 3.5%, with nearly all losses coming in within 30 minutes due to vaccine rollout problems. Moderna stock jumped 10% to a new closing level.

In overnight trading, Pfizer and BioNTech shares fell slightly. MRNA shares rose.

READ  Trump's private bankers quit Deutsche Bank

After the shutdown, Moderna has reaffirmed its goal of providing 20 million doses of the Coronavirus vaccine by the end of the year. You see 100 million to 120 million available worldwide in the first quarter, with 500 million to 1 billion doses in 2021. It also reported that the participants in the first phase maintained high levels of antibodies about 119 days after the first Coronavirus vaccine dose – 90 Day after second dose.

The stimulus package “promising signs”

House Speaker Nancy Pelosi and Senate Majority Leader Mitch McConnell spoke Thursday to affirm their commitment to a new coronavirus stimulus deal, as lawmakers signal more willingness to make concessions and reach an agreement soon. McConnell said earlier in the day that he saw “hopeful signs” of a stimulus package. Pelosi and Senate Minority Leader Chuck Schumer said on Wednesday that a new bipartisan proposal worth $ 908 billion could form the basis of the stimulus deal talks.

On the horizon is the December 11 deadline for government funding.

CrowdStrike and Zscaler stock joined IBD Leaderboard Thursday.

Dow Jones futures today

Dow futures rose 0.4% versus fair value. S&P 500 futures rose 0.35%. Nasdaq 100 futures rose 0.3%.

Dow futures will likely roll in at 8:30 AM ET, when the Labor Department releases its jobs report for November. Economists expect the November jobs report to show non-farm payrolls rising by 500,000, as the pace of the recovery slows. The unemployment rate is expected to decline to 6.8%.

Remember to work on overnight Dow Jones Futures And anywhere else it does not necessarily translate into actual circulation in the next normal cycle Stock market session.


Join IBD experts as they analyze actionable stocks up the stock market on IBD Live.


Coronavirus cases

The number of coronavirus cases around the world has reached 65.66 million. The number of COVID-19 deaths has surpassed 1.51 million.

READ  Italy wins the Eurovision Song Contest

The number of Coronavirus cases in the United States has reached 14.53 million, with the number of deaths exceeding 282,000. Newly diagnosed US COVID-19 cases so far surpassed 218,000 on Thursday with the death toll surpassing 2,900, both of which are new daily records.

With domestic cases rising and hospital admissions, the city of Los Angeles announced a tougher lockdown, which has resulted in the shutdown of all non-essential corporate personal activities. Walking or driving is prohibited, except for basic activities. The much larger Los Angeles County had already shuttered outdoor dining.

California Gov. Gavin Newsom late Thursday announced a limited home stay order for many parts of the state, although his request would allow non-essential retailers to remain open at limited capacity.

Rising coronavirus cases and increasing government shutdowns are increasing the risks of rolling out a coronavirus vaccine and a potential stimulus deal.


Pfizer and Moderna face their biggest challenge: pollinating the world


The stock market rose on Thursday

The stock market rebound at the close was hampered by news of the Pfizer vaccine for the Coronavirus, after a slight rise in hopes of the stimulus package.

The Dow Jones Industrial Average rose 0.3% on Thursday Stock market tradingLed Boeing (Bachelor of). The S&P 500 lost less than 0.1%. The Nasdaq Composite Index rose 0.2%. I faded on Thursday as trading volume increased, meaning it was a day off for the Nasdaq.

between the The best ETFs, The Innovator IBD 50 ETF (fifty) Rose 0.2% but closed near session lows. IShares Technology and Software Extended Fund (ETF)IGV0.5% jump. (VanEck Vectors Semiconductor Foundation)SMH) Lost a small portion.

Read The Big Picture Every day to keep up with the market trend, stocks and leading sectors.


Are you looking for the next big stock market winners? Get started with these three steps

READ  The Oxford Covid-19 vaccine could do more for the world than other vaccines

DocuSign Earnings

DocuSign doubled earnings to 22 cents a share. Revenue rose 53% to $ 382.9 million, in the third consecutive quarter of exponential growth. Analysts expected DocuSign to earn 13 cents on sales of $ 361.2 million.

The e-signature software specialist, the big winner from the home business trend, also announced stronger bills and higher revenues for the current quarter.

In pre-market trading, DocuSign stock surged roughly 5% to 242. For a brief period late on Thursday, DOCU stock crossed 246.90 Point purchase. Investors can see 246.90 as an early entry point or buy from a heavy mess Double bottom base.

DOCU stock rose 6.1% on Thursday to 231.01, bouncing off the 50-day line and breaking the trend line. This could have provided an early entry, but it would have posed a high risk just before DocuSign’s earnings. If DOCU stock doesn’t clear the entry at 246.90 on Thursday, investors may consider starting a position on a 10-week streak.

DocuSign’s earnings report follows bullish results from the stocks of security software leaders CrowdStrike and Zscaler, as well as the search provider Elastic.

CrowdStrike stock rose nearly 14% on Thursday, moving away from the base. ZS stock jumped 26% and flex stock by nearly 13%, which is also a cover of the bases. CRWD stock is IBD stocks today.

Please follow Ed Carson on Twitter at IBD_ECarson Stock market updates and more.

You may also like:

Why simplify this IBD tool burntthe classroom For the highest stock

Get your next winning streak with MarketSmith

Do you want to get quick profits and avoid big losses? Try SwingTrader

Best growth stock to buy and monitor

IBD Digital: Open IBD’s premium stocks, tools, and analytics today

Leave a Reply

Your email address will not be published. Required fields are marked *